Toggle Offcanvas
...
 
Pazopanib Tenders

Pazopanib Tenders

View Pazopanib tenders, RFPs and contracts. Bid on readily available Pazopanib tenders with the best and most comprehensive tendering platform, since 2002.

Bidding for Pazopanib tenders is extremely lucrative for companies of all sizes. Tendering authorities and private companies release thousands of contracts worth millions for procurement of Pazopanib.

Global Tenders stands out as the largest platform dedicated to pharmaceutical tenders and government contracts. Boasting over 20 years of experience in the tender business, GlobalTenders offers the most extensive and reliable Tenders/RFPs/Contracts Database available. The platform aggregates contracts from both public and private sources, connecting with a vast network of over half a million buyers. Employing advanced artificial intelligence, our meticulous process involves gathering information from over a hundred thousand sources. The data is then intelligently categorized into thousands of subcategories for easy filtering and presenting it in a user-friendly format for quick comprehension.

In addition to tender information, we offer in-depth Pazopanib market analysis, bid consultancy services, and insights into top bidders and winners.

Sign up now to get instant access to unlimited Pazopanib tenders, advanced search filters, market analysis, industry trends, tender training and 24/7 customer support.

7 Live Notices for Pazopanib Tenders

Showing 1 to 7

Object: Electronic Auction - Intention To Register Price For Future And Possible Acquisition Of Medicines (Oncological) 03.
country Brazil
posting date18 Oct 2025
deadline01 Nov 2025
Open House Original Discount Contracts 2024-15 - Pazopanib
country Germany
posting date26 Nov 2024
deadline31 Dec 2025
Open House Original Discount Contracts 2024-15 - Pazopanib
country Germany
posting date25 Nov 2024
deadline31 Dec 2025
Open House Original Discount Contracts 2024-15 - Pazopanib
country Germany
posting date25 Nov 2024
deadline31 Dec 2025
Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredient Pazopanib (L01Ex03) Within The Framework Of A So-Called Open-House Model.
country Germany
posting date13 Aug 2024
deadline31 Jul 2026
Nhs National Transition Framework For Apremilast, Pazopanib And Dapagliflozin
country United Kingdom
posting date04 Sep 2025
deadline03 Sep 2026
Supply Of Cancer Drugs To K R Hospital & Super Speciality Hospital, Mmc & Ri, Mysuru.
country India
posting date29 Sep 2025
deadline28 Oct 2025

Share Share this page